Proteomics Market to Grow with a CAGR of 11.32% through 2030
Rising demand for personalized medicine and increasing R&D expenditure
& government funding for proteomics is expected to drive the Global Proteomics
Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Proteomics
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030”, the Global Proteomics Market stood at USD 24.11 Billion in 2024 and is anticipated to grow with a CAGR of 11.32% in the forecast period through 2030. The remarkable growth of the Global Proteomics Market can be
primarily attributed to the surge in research activities focused on
personalized medicine. With the increasing investments in research and
development by pharmaceutical and biotechnology companies, coupled with
continuous technological advancements, the field of proteomics is experiencing
a significant boost. Moreover, the rising amount of monetary support provided
by governments worldwide further fuels the expansion of this market, fostering
innovation and driving breakthrough discoveries in the field.
The proteomics industry is poised for significant growth and advancements in the near future. Proteomics, the study of proteins and their functions within biological systems, plays a crucial role in understanding disease mechanisms, identifying therapeutic targets, and developing personalized medicine approaches. With advancements in technology and analytical techniques, the proteomics industry is expected to witness remarkable progress. One of the key areas of growth is the development of high-throughput proteomics platforms that enable the analysis of large numbers of proteins simultaneously. This allows for a comprehensive understanding of complex protein networks and their interactions, leading to insights into disease pathways and potential biomarkers. Additionally, advancements in mass spectrometry and bioinformatics tools are enhancing the accuracy and speed of protein identification and quantification. This enables researchers to delve deeper into proteomic data and extract meaningful information for drug discovery, precision medicine, and diagnostics. Moreover, the integration of proteomics with other omics technologies, such as genomics and metabolomics, holds immense potential for gaining a holistic understanding of biological systems and disease processes. Overall, the proteomics industry is expected to contribute significantly to advancements in medical research, diagnostics, and therapeutic development, ultimately leading to improved patient outcomes soon.
Another growth driver of the Global Proteomics Market is the increasing prevalence of cancer and other diseases. Ongoing proteomics research can aid doctors in understanding how proteins react in dynamic environments, such as in patients with cancer. The field of proteomics can provide significant information in the form of biomarkers. However, there are also significant challenges to the growth of the Global Proteomics Market. Venturing into proteomics requires substantial capital expenditure on equipment and carries the risk of failure due to the trial-and-error nature of research. Despite these challenges, the proteomics market presents several growth opportunities as a relatively new technology that has shown considerable progress. Nanoproteomics, which combines nanotechnology with proteomics, is expected to have a positive impact on market growth in the forecast period.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Proteomics Market.”
The Global Proteomics Market is segmented into product, technology, application, type, end user, regional distribution, and company.
Based on Product, Software & Services represent the fastest-growing category in the global proteomics market. This growth is largely driven by the increasing complexity of proteomics research, which requires advanced data analysis, bioinformatics tools, and specialized expertise that many labs or healthcare organizations prefer to outsource or manage through software platforms. As proteomic techniques like mass spectrometry, protein microarrays, and single-cell proteomics become more sophisticated, the need for efficient data handling and interpretation tools has grown significantly. This has led to a sharp rise in the adoption of customized software solutions and professional services, especially for tasks such as protein identification, quantification, and functional analysis. Moreover, the expansion of cloud-based tools, artificial intelligence, and machine learning applications in biological data interpretation is further propelling the software and services segment forward. These technologies enable faster, more accurate insights from large proteomic datasets, which is especially beneficial in drug discovery, biomarker validation, and personalized medicine. Additionally, many pharmaceutical and biotechnology companies, especially in emerging markets, are increasingly relying on external service providers to manage complex proteomic workflows. This outsourcing trend adds further momentum to the segment’s growth.
Based on Region, The Asia-Pacific region is witnessing the fastest growth in the global proteomics market due to increasing investments in biotechnology, rising healthcare expenditure, and growing awareness of precision medicine. The region benefits from a large population base, a rising prevalence of chronic diseases, and an expanding network of research institutions. Additionally, supportive government initiatives and funding in countries like China, India, and South Korea are accelerating the adoption of advanced proteomics technologies. These factors collectively make Asia-Pacific the most rapidly growing region in this market.
Major companies operating in
Global Proteomics Market are:
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Bruker Corporation
- Promega Corporation
- Agilent Technologies Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F Hoffmann-La Roche Ltd.
- Luminex Corporation
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The growing preference for personalized drugs,
coupled with the increasing focus on research and development in drug discovery
and biotechnology, serves as the primary driver for market growth. Proteomic
systems play a pivotal role in reducing the time, cost, and resources required
for chemical synthesis and biological testing of drugs, thereby simplifying the
drug discovery process. Moreover, the market is further propelled by
opportunities associated with biomarker identification and mass spectrometry-based
proteomics. Additionally, the market benefits from the rising technological
penetration in comprehensive protein analysis techniques, enabling
comprehensive quantitative and qualitative analysis of proteins, as well as
identification of cancer therapies and treatments. Furthermore, favorable
government policies supporting extensive research and development (R&D)
efforts contribute to the market's growth.,” said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Proteomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagents & Assays, Instruments, Software & Services), By Technology (Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis), By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By Type (Expression, Functional, Structural, Computational), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global
Proteomics Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Proteomics Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com